Bellicum Pharma (BLCM) Reports Q3 Loss Per Share of $0.51

Bellicum Pharma (NASDAQ: BLCM) reported Q3 EPS of ($0.51), versus $2.08 reported last year.

For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings